학술논문
Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab
Document Type
Article
Author
Source
In: Urologic Oncology: Seminars and Original Investigations . (Urologic Oncology: Seminars and Original Investigations, November 2023, 41(11):459.e1-459.e8)
Subject
Language
English
ISSN
18732496
10781439
10781439